258 related articles for article (PubMed ID: 11443221)
41. Aromatase and 17 beta-hydroxysteroid dehydrogenase type 1 in human breast carcinoma.
Sasano H; Frost AR; Saitoh R; Harada N; Poutanen M; Vihko R; Bulun SE; Silverberg SG; Nagura H
J Clin Endocrinol Metab; 1996 Nov; 81(11):4042-6. PubMed ID: 8923858
[TBL] [Abstract][Full Text] [Related]
42. Estrogen formation in endometrial and cervix cancer cell lines: involvement of aromatase, steroid sulfatase and 17beta-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12).
Fournier MA; Poirier D
Mol Cell Endocrinol; 2009 Mar; 301(1-2):142-5. PubMed ID: 18817841
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of type 1 17β-hydroxysteroid dehydrogenase impairs the synthesis of 17β-estradiol in endometriosis lesions.
Delvoux B; D'Hooghe T; Kyama C; Koskimies P; Hermans RJ; Dunselman GA; Romano A
J Clin Endocrinol Metab; 2014 Jan; 99(1):276-84. PubMed ID: 24187399
[TBL] [Abstract][Full Text] [Related]
44. [Temporal and spatial expression of estrogen activity-related molecules in eutopic endometrium of adenomyosis].
Guo ZR; Zhang J; Lang JH; Leng JH; Piao YS; Wang YL
Zhonghua Fu Chan Ke Za Zhi; 2004 Apr; 39(4):246-9. PubMed ID: 15130351
[TBL] [Abstract][Full Text] [Related]
45. Localization of type 7 17beta-hydroxysteroid dehydrogenase in mouse tissues. In situ hybridization studies.
Pelletier G; Luu-The V; Li S; Labrie F
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):49-57. PubMed ID: 15748832
[TBL] [Abstract][Full Text] [Related]
46. Expression of enzymes involved in estrogen metabolism in human prostate.
Takase Y; Lévesque MH; Luu-The V; El-Alfy M; Labrie F; Pelletier G
J Histochem Cytochem; 2006 Aug; 54(8):911-21. PubMed ID: 16651392
[TBL] [Abstract][Full Text] [Related]
47. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H
Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221
[TBL] [Abstract][Full Text] [Related]
48. Blocking 17β-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach.
Konings GF; Cornel KM; Xanthoulea S; Delvoux B; Skowron MA; Kooreman L; Koskimies P; Krakstad C; Salvesen HB; van Kuijk K; Schrooders YJ; Vooijs M; Groot AJ; Bongers MY; Kruitwagen RF; ; Romano A
J Pathol; 2018 Feb; 244(2):203-214. PubMed ID: 29144553
[TBL] [Abstract][Full Text] [Related]
49. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables.
Ozuysal S; Oztürk H; Bilgin T; Filiz G
Arch Gynecol Obstet; 2005 Feb; 271(2):123-6. PubMed ID: 14740230
[TBL] [Abstract][Full Text] [Related]
50. 17 beta-Hydroxysteroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium.
Casey ML; MacDonald PC; Andersson S
J Clin Invest; 1994 Nov; 94(5):2135-41. PubMed ID: 7962560
[TBL] [Abstract][Full Text] [Related]
51. 17Beta-hydroxysteroid dehydrogenase type 12 in human breast carcinoma: a prognostic factor via potential regulation of fatty acid synthesis.
Nagasaki S; Suzuki T; Miki Y; Akahira J; Kitada K; Ishida T; Handa H; Ohuchi N; Sasano H
Cancer Res; 2009 Feb; 69(4):1392-9. PubMed ID: 19190350
[TBL] [Abstract][Full Text] [Related]
52. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
[TBL] [Abstract][Full Text] [Related]
53. The effect of obesity on the ratio of type 3 17beta-hydroxysteroid dehydrogenase mRNA to cytochrome P450 aromatase mRNA in subcutaneous abdominal and intra-abdominal adipose tissue of women.
Corbould AM; Bawden MJ; Lavranos TC; Rodgers RJ; Judd SJ
Int J Obes Relat Metab Disord; 2002 Feb; 26(2):165-75. PubMed ID: 11850747
[TBL] [Abstract][Full Text] [Related]
54. Steroid sulphotransferase and 17beta-hydroxysteroid dehydrogenase activities in Ishikawa human endometrial adenocarcinoma cells.
Chetrite G; Pasqualini JR
J Steroid Biochem Mol Biol; 1997 Apr; 61(1-2):27-34. PubMed ID: 9328207
[TBL] [Abstract][Full Text] [Related]
55. Characterization of 17beta-hydroxysteroid dehydrogenase type 4 in human ovarian surface epithelial cells.
Nagayoshi Y; Ohba T; Yamamoto H; Miyahara Y; Tashiro H; Katabuchi H; Okamura H
Mol Hum Reprod; 2005 Sep; 11(9):615-21. PubMed ID: 16219629
[TBL] [Abstract][Full Text] [Related]
56. Androgen formation and metabolism in the pulmonary epithelial cell line A549: expression of 17beta-hydroxysteroid dehydrogenase type 5 and 3alpha-hydroxysteroid dehydrogenase type 3.
Provost PR; Blomquist CH; Godin C; Huang XF; Flamand N; Luu-The V; Nadeau D; Tremblay Y
Endocrinology; 2000 Aug; 141(8):2786-94. PubMed ID: 10919264
[TBL] [Abstract][Full Text] [Related]
57. An assessment of the multifactorial profile of steroid-metabolizing enzymes and steroid receptors in the eutopic endometrium during moderate to severe ovarian endometriosis.
Anupa G; Sharma JB; Roy KK; Sengupta J; Ghosh D
Reprod Biol Endocrinol; 2019 Dec; 17(1):111. PubMed ID: 31878927
[TBL] [Abstract][Full Text] [Related]
58. 17β-Hydroxysteroid Dehydrogenase Type 2 Expression Is Induced by Androgen Signaling in Endometrial Cancer.
Hashimoto C; Miki Y; Tanaka S; Takagi K; Fue M; Doe Z; Li B; Yaegashi N; Suzuki T; Ito K
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642629
[TBL] [Abstract][Full Text] [Related]
59. AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer.
Rizner TL; Smuc T; Rupreht R; Sinkovec J; Penning TM
Mol Cell Endocrinol; 2006 Mar; 248(1-2):126-35. PubMed ID: 16338060
[TBL] [Abstract][Full Text] [Related]
60. Aromatase and sex steroid receptors in human vena cava.
Sasano H; Murakami H; Shizawa S; Satomi S; Nagura H; Harada N
Endocr J; 1999 Apr; 46(2):233-42. PubMed ID: 10460007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
